Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Northern Ireland NHS Contract

23rd Aug 2006 07:01

Advanced Medical Solutions Grp PLC23 August 2006 For immediate release 23 August 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") ActivHeal(R) on contract for NHS hospitals in Northern Ireland Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalwoundcare technology company, today announces that it has been selected by theCentral Services Agency Regional Supplies Service for inclusion on a contractto supply the NHS hospitals of Northern Ireland with ActivHeal(R) hydrocolloidsand foam woundcare products. This is with effect from 1st October and initialestimates indicate a conservative uptake of approximately £100k per annum. ActivHeal(R) is a value range of advanced woundcare dressings specificallydesigned by AMS for use on routine wounds. Independent technical and clinicalassessment has shown that the ActivHeal(R) products are equivalent to thebranded versions in performance whilst significantly reducing the cost oftreatment. ActivHeal(R) offers real and immediate savings to the NHS of approximately £25million per year. These savings on the treatment of routine wounds areavailable to ensure that the new technologies needed for problematic cases areaffordable within current budgets. As a UK based R & D and manufacturingcompany, AMS is also involved in delivering new innovative woundcaretechnologies to the market through its branded marketing and distributionpartners. Commenting on this announcement Dr. Don Evans, Chief Executive of AMS, stated: "I am delighted that we have been selected to supply our products into the NHShospitals of Northern Ireland. This is a further endorsement of our ActivHeal(R)range of woundcare dressings which provide the NHS with a range of woundcareproducts that are cost effective but do not compromise patient care. This newcontract is encouraging as it reflects AMS' success in penetrating the NHSparticularly at a time when Hospital Trusts are trying to reduce spend." For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Advanced Medical Solutions Group
FTSE 100 Latest
Value8,407.44
Change4.26